Want to join the conversation?
Therapeutic products maker $ANIK said the US FDA Office of Combination Products has allotted CINGAL, used to treat joint pain due to osteoarthritis, to the Center for Drug Evaluation and Research as the lead center for premarket review. Though $ANIK disagrees with FDA's decision, it intends to move swiftly to take CINGAL through regulatory review.
$SBUX launched its annual “Starbucks for Life” competition in the U.S. and Canada. The winner of the competition will receive a credit of one drink or food item per day for a duration of 30 years.
$T shares rose 1.8%, as a big boost for the S&P 500. The company said its new streaming television service DirectTV has so far exceeded expectations.
$TXMD flying high.. anyone here to catch..?
$CMG crashing. There seems to be nothing good to read about this company.